DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20213854

A prospective study of clinicoepidemiology, metabolic and hormonal profile of women with hirsutism in Konaseema region of Andhra Pradesh

M. Smitha

Abstract


Background: Hirsutism is defined as presence of excess coarse hairs appear in male pattern in women.There is various aetiology of hirsutism like Idiopathic hirsutism, PCOS, androgen secreting ovarian tumours, menopause, CAH, Cushing’s syndrome, drugs which increases testosterone level, insulin resistance and tumour secreting androgen. We have designed present study with an aim to study the clinicoepidemiology, metabolic and hormonal profile of women with hirsutism in Konaseema region of Andhra Pradesh.

Methods: All patients with hirsutism attending gynaecology outpatient department were selected for study based on inclusion and exclusion criteria. After that patient were examined clinically, BMI was calculated for each patient. Patients were clinically evaluated for signs of excess androgen secretion, Cushing syndrome, metabolic syndrome and hyperprolactinemia. Modified Ferriman-Gallwey scoring system was used for evaluating and quantifying hirsutism.

Results: The mean Fasting plasma insulin12.42±2.41 (mIU/dl), the mean of HOMA-IR was 3.14±1.18. The mean value of dehydroepiandrosteronesulphate (DHEAS) 355.78±15.41 mcg/dl. There was statistically significant reduction in modified Ferriman-Gallwey scoring in before and after treatment (12.38± 1.55 vs. 9.62±1.6), the p value was 0.00001. The number of patients with menstrual irregularities were reduced from 63.3% to 20% after treatment and this difference is statistically significant (p=0.04).

Conclusions: Hirsutism is associated with insulin resistance and DHEAS concentration was high. Modified Ferriman-Gallwey score was significantly reduced and there was significant weight loss and improvement in menstrual irregularities after treatment.


Keywords


Clinicoepidemiology, Metabolic, Hormonal profile of women, Hirsutism

Full Text:

PDF

References


Rittmaster RS. Hirsutism. Lancet. 1997;349(9046): 191-5.

Phillipov G. Hirsutism. Lancet. 1997;349(9052):650.

Braithwaite SS, Jabamoni R. Hirsutism. Arch Dermatol. 1983;119(4):279-84.

Sharma NL, Mahajan VK, Jindal R, Gupta M, Lath A. Hirsutism: clinico-investigative profile of 50 Indian patients. Indian J Dermatol. 2008;53(3):111-4.

Chhabra S, Gautam RK, Kulshreshtha B, Prasad A, Sharma N. Hirsutism: A Clinico-investigative Study. Int J Trichology. 2012;4(4):246-50.

Krysiak R, Kedzia A, Okopień B. Current opinions on the etiology and pathophysiology of hirsutism. Pol Merkur Lekarski. 2012;32(191):335-40.

Sharma D, Shanker V, Tegta G, Gupta M, Verma GK. Clinico-investigative Profile of Patients of Hirsutism in a Tertiary Level Institution. Int J Trichology. 2012; 4(2):69-74.

Dhanotia PG, Shah BJ, Dhamale SS. A study of clinical and investigational profile of hirsute women at a tertiary care center in Western India. Clin Dermatol Rev. 2020;4:123-7

Ikram KM, Pushpinder SC, Monika C, Karaninder SM, Vijay KS, Anuj S, et al. Clinico-investigative attributes of 122 patients with hirsutism: A 5-year retrospective study from India. Int J Women's Dermatol. 2021;7(3): 237-42.

Daniel WW. Biostatistics: A Foundation for analysis in the health sciences. 7th ed. New York: John Wiley & Sons. 1999.

Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440-7.

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.

Tehrani FR, Rashidi H, Azizi F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran lipid and glucose study. Reprod Biol Endocrinol. 2011;9:144.

Escobar-Morreale HF, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012;18(2):146-70.

Chhabra S, Gautam RK, Kulshreshtha B, Prasad A, Sharma N. Hirsutism: A Clinico-investigative Study. Int J Trichology. 2012;4(4):246-50.

Roth LW, Huang H, Legro RS, Diamond MP, Coutifaris C, Carson SA, et al. Altering hirsutism through ovulation induction in women with polycystic ovary syndrome. Obstet Gynecol. 2012;119(6):1151-6.

Li R, Qiao J, Yang D, Li S, Lu S, Wu X, Wei Z. Epidemiology of hirsutism among women of reproductive age in the community: a simplified scoring system. Eur J Obstet Gynecol Reprod Biol. 2012;163(2):165-9.

Mina A, Aida F, Ali S, Fatemeh M. Prevalence of idiopathic hirsutism: A systematic review and meta-analysis. J Cosmetic Dermatol. 2021;5:85-9.

Ruutiainen K, Erkkola R, Grönroos MA, Irjala K. Influence of body mass index and age on the grade of hair growth in hirsute women of reproductive ages. Fertil Steril. 1988;50(2):260-5.

Couto Alves A, Valcarcel B, Mäkinen VP, Morin-Papunen L, Sebert S, Kangas AJ, et al. Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity. Int J Obes (Lond). 2017;41(9):1331-1340.

Glueck CJ, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertility Sterility. 2001;75(1):46-52.

Cebeci F, Onsun N, Mert M. Insulin resistance in women with hirsutism. Arch Med Sci. 2012;8(2):342-6.

Talaei A, Adgi Z, MohamadiKelishadi M. Idiopathic hirsutism and insulin resistance. Int J Endocrinol. 2013;2013:593197.

Sachdeva S. Hirsutism: evaluation and treatment. Indian J Dermatol. 2010;55(1):3-7.

Pasquali R, Zanotti L, Fanelli F, Mezzullo M, Fazzini A, MorselliLabate AM, et al. Defining Hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective. J Clin Endocrinol Metab. 2016;101(5):2013-22.

Kathryn A. Martin, R. Jeffrey C, David AE, Lourdes I, Rogerio A. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol. 2008; 93(4):1105-20.